Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-15-039548
Filing Date
2015-06-29
Accepted
2015-06-29 09:10:38
Documents
3
Period of Report
2015-06-29

Document Format Files

Seq Description Document Type Size
1 6-K v414307_6k.htm 6-K 10314
2 EXHIBIT 99.1 v414307_ex99-1.htm EX-99.1 9896
3 GRAPHIC image_002.jpg GRAPHIC 3174
  Complete submission text file 0001144204-15-039548.txt   25764
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
BIO BLAST PHARMA LTD. (Filer) CIK: 0001596812 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36578 | Film No.: 15956729
SIC: 2834 Pharmaceutical Preparations